18
Participants
Start Date
March 31, 2005
Primary Completion Date
July 31, 2006
Study Completion Date
July 31, 2006
Oral Testosterone
200 mg (Formulation A) Day 1 400 mg (Formulation A) Day 2, fasting; Day 3, with food 200 mg (Formulation B) Day 8, fasting 400 mg (Formulation B) Day 9, fasting; Day 10, with food
Leuprolide (Lupron)
7.5 mg injection into muscle (once) (Day -14)
Dutasteride
24.5 mg load (3.5 mg x 7 capsulesDay -14 only) 0.5 mg daily (Day -13 to day -1)
University of Washington, Seattle
Collaborators (1)
GlaxoSmithKline
INDUSTRY
National Institutes of Health (NIH)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Washington
OTHER